These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6435915)

  • 1. Sodium taurocholate effect on beta-glucosidase activity: a new approach for identification of Gaucher disease using the synthetic substrate and leucocytes.
    Magalhães J; Sá Miranda MC; Pinto R; Lemos M; Poenaru L
    Clin Chim Acta; 1984 Aug; 141(2-3):111-8. PubMed ID: 6435915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic substrate beta-glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher's disease.
    Wenger DA; Clark C; Sattler M; Wharton C
    Clin Genet; 1978 Feb; 13(2):145-53. PubMed ID: 23912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved fluorometric leukocyte beta-glucosidase assay for Gaucher's disease.
    Daniels LB; Glew RH; Diven WF; Lee RE; Radin NS
    Clin Chim Acta; 1981 Sep; 115(3):369-75. PubMed ID: 6794954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygote detection of type I Gaucher disease using blood platelets.
    Nakagawa S; Kumin S; Sachs G; Nitowsky HM
    Clin Chim Acta; 1982 Jan; 118(1):99-107. PubMed ID: 6797762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher's disease II. Studies on the kinetics of beta-glucosidase and the effects of sodium taurocholate in normal and Gaucher tissues.
    Choy FY; Davidson RG
    Pediatr Res; 1980 Jan; 14(1):54-9. PubMed ID: 6767218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease.
    Raghavan SS; Topol J; Kolodny EH
    Am J Hum Genet; 1980 Mar; 32(2):158-73. PubMed ID: 6770675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of 4-heptylumbelliferyl-beta-D-glucoside to identify Gaucher's disease heterozygotes.
    Butcher BA; Gopalan V; Lee RE; Richards TC; Waggoner AS; Glew RH
    Clin Chim Acta; 1989 Oct; 184(3):235-42. PubMed ID: 2515009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay of the beta-glucosidase activity with natural labelled and artificial substrates in leukocytes from homozygotes and heterozygotes with the Norrbottnian type (Type 3) of Gaucher disease.
    Svennerholm L; Håkansson G; Dreborg S
    Clin Chim Acta; 1980 Sep; 106(2):183-93. PubMed ID: 6773705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of various beta-glucosidase assays used to diagnose Gaucher's disease.
    Chiao YB; Glew RH; Diven WF; Lee RE
    Clin Chim Acta; 1980 Jul; 105(1):41-50. PubMed ID: 6772352
    [No Abstract]   [Full Text] [Related]  

  • 10. [Laboratory diagnosis of Gaucher's disease. Value of leukocyte beta-glucosidase determination].
    Turpin JC; Bauman N; Castaigne P
    Nouv Presse Med; 1972 Jun; 1(23):1579-81. PubMed ID: 5035886
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple forms of membrane-bound beta-glucosidase in human leucocytes.
    Carroll M
    Biochem Soc Trans; 1981 Feb; 9(1):129-30. PubMed ID: 6783452
    [No Abstract]   [Full Text] [Related]  

  • 12. Heterozygote detection of type I Gaucher disease using blood platelets.
    Nakagawa S; Kumin S; Sachs G; Nitowsky HM
    Prog Clin Biol Res; 1982; 95():597-602. PubMed ID: 6812088
    [No Abstract]   [Full Text] [Related]  

  • 13. A microassay for Gaucher's disease.
    Peters SP; Lee RE; Glew RH
    Clin Chim Acta; 1975 May; 60(3):391-6. PubMed ID: 806404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay of beta-glucosidase and sphingomyelinase for identification of patients and carriers of Gaucher's and Niemann-Pick diseases.
    Wenger DA
    Adv Exp Med Biol; 1978; 101():707-17. PubMed ID: 208369
    [No Abstract]   [Full Text] [Related]  

  • 15. The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes.
    Beutler E; Kuhl W
    J Lab Clin Med; 1970 Nov; 76(5):747-55. PubMed ID: 5477334
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
    Gatt S; Dinur T; Osiecki K; Desnick RJ; Grabowski GA
    Enzyme; 1985; 33(2):109-19. PubMed ID: 3924590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients.
    Grabowski GA; Goldblatt J; Dinur T; Kruse J; Svennerholm L; Gatt S; Desnick RJ
    Am J Med Genet; 1985 Jul; 21(3):529-49. PubMed ID: 3927728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Gaucher's disease in cultured skin fibroblasts and leucocytes.
    Butterworth J; Broadhead DM
    J Inherit Metab Dis; 1978; 1(3):111-3. PubMed ID: 116079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-Glucosidase assays in the diagnosis of Gaucher's disease.
    Daniels LB; Glew RH
    Clin Chem; 1982 Apr; 28(4 Pt 1):569-77. PubMed ID: 6804115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaucher disease: accurate identification of asymptomatic French-Canadian carrier using nonlabeled authentic sphingolipid substrate N-palmitoyl dihydroglucocerebroside.
    Choy FY; Bouillon L; Laurin CA
    Am J Med Genet; 1987 Aug; 27(4):895-905. PubMed ID: 3425599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.